Halofuginone hydrobromide NEW
| Price | $31 | $44 | $72 |
| Package | 1mg | 2mg | 5mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-25 |
Product Details
| Product Name: Halofuginone hydrobromide | CAS No.: 64924-67-0 |
| Purity: 99.73% | Supply Ability: 10g |
| Release date: 2026/05/25 |
Product Introduction
Bioactivity
| Name | Halofuginone hydrobromide |
| Description | Halofuginone specifically inhibits collagen type I gene expression and matrix metalloproteinase 2 (MMP-2) gene expression, which may result in the suppression of angiogenesis, tumor stromal cell development, and tumor cell growth. Halofuginone Hydrobromide is the hydrobromide salt of halofuginone, a semisynthetic quinazolinone alkaloid anticoccidial derived from the plant Dichroa febrifuga, with antifibrotic and potential antineoplastic activities. These effects appear to be due to halofuginone-mediated inhibition of the collagen type I and MMP-2 promoters. Collagen type I and MMP-2 play important roles in fibroproliferative diseases. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (4.04 mM), Sonication is recommended. DMSO : 17 mg/mL (34.3 mM), Sonication is recommended. |
| Keywords | type-I | Transforming growth factor beta | TGF-β/Smad | TGF-β | TGFβ | TGF-beta/Smad | TGFbeta/Smad | TGF-beta | TGFbeta | TGF-b/Smad | TGFb | SodiumChannel | Sodium Channel | Smad | RU-19110 | RU19110 | RU 19110 | RNASynthesis | RNA Synthesis | ProRS | prolyl-tRNA synthetase | prolyl-tRNA | Parasite | osteoarthritis | Na+ channels | Na channels | Inhibitor | inhibit | Halofuginone hydrobromide | Halofuginone | DNASynthesis | DNA/RNA Synthesis | DNA Synthesis | CalciumChannel | Calcium Channel | Ca2+ channels | Ca channels |
| Inhibitors Related | 2,4,6-Tri-tert-butylphenol | Phenytoin sodium | Kojic acid | Guanidine hydrochloride | Hydroxychloroquine | Hexane-1,6-diol | Metronidazole | 2-Amino-2-methyl-1-propanol | Doxycycline | Fenpyroximate | Thymidine | Magnesium Chloride Hexahydrate |
| Related Compound Libraries | Anti-Parasitic Compound Library | Bioactive Compound Library | Alkaloid Natural Product Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Neuroprotective Compound Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | TGF-beta/Smad Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $10.00 |
VIP4Y
|
Enki Biopharmaceuticals (Shanghai) Limited
|
2026-06-05 | |
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-13 | ||
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-10 | ||
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-02 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY